«Mathematical modeling can identify ways to limit
aggressive tumor cell growth.»
Not exact matches
«Cancer
cells disguise themselves by switching off genes, new research reveals: A genome - wide map of the genes switched off in
aggressive tumors reveals a «signature».»
Scientists have uncovered how
tumor cells in
aggressive uterine cancer can switch disguises and spread so quickly to other parts of the body.
They told her she needed
aggressive chemotherapy and radiation to kill the cancer
cells in her softball - sized
tumor.
In human
cells and in mice, the virus infected and killed the stem
cells that become a glioblastoma, an
aggressive brain
tumor, but left healthy brain
cells alone.
Metastasis, the strategy adopted by
tumor cells to transform into an
aggressive form of cancer, are often associated with a gloomy prognosis.
«It was really surprizing to realize that oncogenic Pik3ca in basal
cells induced the formation of luminal tumours, while its expression in luminal
cells gave rise to heterogeneous and more
aggressive tumors including basal - like
tumors,» comments Alexandra Van Keymeulen, the first author of the paper.
The team was surprised to observe that these very
aggressive tumors arise from mature, pigment - producing
cells called melanocytes.
The luminal
cells generally lead to more
aggressive tumors.
Conventional, high - dose chemotherapy treatments can cause the fibroblast
cells surrounding
tumors to secrete proteins that promote the
tumors» recurrence in more
aggressive forms, researchers at Taipei Medical University and the National Institute of Cancer Research in Taiwan and University of California, San Francisco, have discovered.
An experimental drug in early development for
aggressive brain
tumors can cross the blood - brain
tumor barrier, kill
tumor cells and block the growth of
tumor blood vessels, according to a study led by researchers at the Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James).
Several studies have supported a role for cancer stem
cells in the
aggressive brain
tumors called glioblastoma, but those studies involved inducing human
tumors to grow in mice, and as such their relevance to cancer in humans has been questioned.
«
Tumor cells closer to 1 were more similar to stem cells and significantly more aggressive than tumor cells closer to 0,» Malta
Tumor cells closer to 1 were more similar to stem
cells and significantly more
aggressive than
tumor cells closer to 0,» Malta
tumor cells closer to 0,» Malta said.
Drugs that enhance a process called oxidative stress were found to kill rhabdomyosarcoma
tumor cells growing in the laboratory and possibly bolstered the effectiveness of chemotherapy against this
aggressive tumor of muscle and other soft tissue.
In this study, we found that chloroquine not only has an effect on the growth of the cancer
cells, but also makes the
tumor environment less
aggressive by normalizing the abnormal blood vessels in the
tumor,» says Patrizia Agostinis.
«
Aggressive cancers contain regions where the cancer
cells are starved for oxygen and die off, yet patients with these
tumors generally have the worst outcome.
«By understanding how stress accelerates invasion in
aggressive breast
tumor cells, this work will inform future studies into whether beta - blockers could be a useful adjuvant therapy in the treatment of some
aggressive breast cancers.»
Because of this lack of receptors, common cancer drugs can't «find» the
cells, and doctors must treat the cancer with extremely
aggressive and highly toxic treatment strategies,» said Salman Hyder, the Zalk Endowed Professor in
Tumor Angiogenesis and professor of biomedical sciences in the College of Veterinary Medicine and the Dalton Cardiovascular Research Center.
Of the 297, 127 people had glioblastoma and 170 had a lower grade glioma, which is also a
tumor of glial
cells, but less
aggressive than glioblastoma.
«We found a striking difference between the metabolic profiles of poorly
aggressive and highly
aggressive ovarian
tumor cells, particularly with respect to their production and use of the amino acid glutamine,» said lead researcher Deepak Nagrath of Rice.
Genetically modified Salmonella bacteria target
tumors and make the immune system extra
aggressive toward cancer
cells.
By tracking and understanding which host
cell pathways are manipulated by these T. gondii proteins, scientists can identify potential new targets to develop more effective therapies against highly
aggressive solid
tumors.
«New
tumor analysis method identifies high - risk prostate cancer: Cancer
cells» genetic pathways show which patients are likely to develop
aggressive types of the disease.»
They found that, by using math models to understand the complex dynamics within cancers, they could use small changes in the environment to promote the growth of
cells that are less
aggressive and thereby decrease
tumor growth.
Study leader Fausto J. Rodriguez, M.D., associate professor of pathology at the Johns Hopkins University School of Medicine and member of the Johns Hopkins Kimmel Cancer Center, says the new study sought to sort out what makes the more
aggressive NF1 - related
tumors genetically different from low grade
tumors and normal, healthy
cells.
Genetically modified «hunter» T
cells successfully migrated to and penetrated a deadly type of brain
tumor known as glioblastoma (GBM) in a clinical trial of the new therapy, but the
cells triggered an immunosuppressive
tumor microenvironment and faced a complex mutational landscape that will need to be overcome to better treat this
aggressive cancer, Penn Medicine researchers report in a new study this week in Science Translational Medicine.
Previous in vitro studies conducted by researchers in other countries showed that this molecule was able to reduce the multiplication and increase the mortality of
cells from melanoma, the most
aggressive type of skin cancer, as well as breast cancer and neuroblastoma, a
tumor that typically affects patients aged 15 or younger.
Chimeric antigen receptor (CAR) T
cell therapy, which edits a cancer patient's T
cells to recognize their
tumors, has successfully helped patients with
aggressive blood cancers but has yet to show the ability to treat solid
tumors.
This causes genomic instability in developing immune
cells and, in the absence of a working
tumor suppressor protein such as p53, an
aggressive form of lymphoma develops in mice.
A doctor treating a patient with a potentially fatal metastatic breast
tumor would be very pleased to find, after administering a round of treatment, that the primary
tumor had undergone a change in character — from
aggressive to static, and no longer shedding
cells that can colonize distant organs of the body.
A new study shows coibamide A has potent anti-cancer activity in mice and
cell cultures that model brain
tumors and triple negative breast cancer, two of the most
aggressive and difficult - to - treat types of cancer.
For years, scientists have observed that
tumor cells from certain breast cancer patients with
aggressive forms of the disease contained low levels of mitochondrial DNA.
The study's findings, published in the journal Cancer Research, are the first to use these combined agents as an immune stimulator and may have the potential to kill cancerous
cells in solid
tumors, including some of the most
aggressive cancers that form in the lung and pancreas.
Such targets have recently been discovered in
cell lines derived from
aggressive childhood
tumors using phenotypic profiling and RNAi screening.
Hypoxia, or a lack of oxygen, is one example of a phenomenon that should weaken the
tumor, but instead, the malignant
cells are able to compensate and drive more
aggressive disease behavior.
These
cells are thought to break off from the original
tumor and circulate in the blood, and may be a sign of an
aggressive tumor.
Not surprisingly, the more
aggressive a
tumor, the more likely it is to engraft — probably because those cancer
cells are particularly adept at growing and spreading.
Loskog AS, Fransson ME, and Totterman TT AdCD40L gene therapy counteracts T regulatory
cells and cures
aggressive tumors in an orthotopic bladder cancer model.
However, unfortunately the mechanisms of
tumor cells have the ability to resist to immunotherapy and patients who relapse with acquired resistance to BRAF and MEK inhibitors often present with melanomas that display a much more
aggressive and invasive phenotype [13, 14].
University of Hawai'i Cancer Center researchers have identified an essential driver of
tumor cell invasion in glioblastoma, the most
aggressive form of brain cancer that can occur at any age.
«With 100 million mutations, each capable of altering a protein in some way, there is a high probability that a significant minority of
tumor cells will survive, even after
aggressive treatment,» said study director Chung - I Wu, PhD, professor of ecology and evolution at the University of Chicago.
In the new study, published online March 27, 2018, in
Cell Reports, a team led by UCSF's David Raleigh, MD, PhD, found that increased activity of a gene known as FOXM1 appears to be responsible for the
aggressive growth and frequent recurrence of these
tumors.
LA JOLLA, CA — Scientists have long believed that glioblastoma multiforme (GBM), the most
aggressive type of primary brain
tumor, begins in glial
cells that make up supportive tissue in the brain...
It has been postulated that hypoxia contributes directly to the development of more
aggressive cancers by exerting selective pressure on the
tumor cell population to favor
cells that can survive decreased O2 and nutrients [18 — 20].
The CRISPR - Cas9 genome editing system could help fight cancer, and now, researchers have used the tool to target what they call cancer's command center, in a treatment that's been shown in mice to shrink
aggressive tumors and increase survival rates, without harming healthy
cells.
«
Tumor cells closer to 1 were more similar to stem cells and significantly more aggressive than tumor cells closer to 0,» Dr. Malta
Tumor cells closer to 1 were more similar to stem
cells and significantly more
aggressive than
tumor cells closer to 0,» Dr. Malta
tumor cells closer to 0,» Dr. Malta said.
«We expected Ezh2 to be an oncogene in this
aggressive tumor, but our gene - editing work revealed it to be a tumor suppressor,» said corresponding author Martine Roussel, Ph.D., a member of the Department of Tumor Cell Biology at St. Jude Children's Research Hosp
tumor, but our gene - editing work revealed it to be a
tumor suppressor,» said corresponding author Martine Roussel, Ph.D., a member of the Department of Tumor Cell Biology at St. Jude Children's Research Hosp
tumor suppressor,» said corresponding author Martine Roussel, Ph.D., a member of the Department of
Tumor Cell Biology at St. Jude Children's Research Hosp
Tumor Cell Biology at St. Jude Children's Research Hospital.
«It appears that a conspiracy among three proteins is required to drive this most
aggressive form of medulloblastoma, but the precise details of interaction still need to be worked out,» said co-author Charles J. Sherr, M.D., Ph.D., chair of the St. Jude Department of
Tumor Cell Biology and a Howard Hughes Medical Institute (HHMI) investigator.
«This has important implications for
tumor development because certain
cells might be more
aggressive than others,» Beck said.
Although some
tumors may be formed by initiating
cells that do not resemble stem
cells, it is likely that stem
cell — like
tumor cells are more
aggressive at forming
tumors, with a higher likelihood of relapse and metastasis.